Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a worry, these businesses can invest more in growth, innovation, or buybacks and dividends.
Even among the companies with sound capital structures, only a few stand out, and we’re here to help you identify them. Keeping that in mind, here are three companies with net cash positions that balance growth with stability.
Monolithic Power Systems (MPWR)
Net cash position: $1.09 billion (2% of Market Cap)
Founded in 1997 by its longtime CEO Michael Hsing, Monolithic Power Systems (NASDAQ: MPWR) is an analog and mixed signal chipmaker that specializes in power management chips meant to minimize total energy consumption.
Why Is MPWR a Top Pick?
- Annual revenue growth of 27.6% over the past five years was outstanding, reflecting market share gains this cycle
- Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 29.9% outpaced its revenue gains
- Industry-leading 43.3% return on capital demonstrates management’s skill in finding high-return investments
Monolithic Power Systems’s stock price of $1,155 implies a valuation ratio of 29.6x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Clover Health (CLOV)
Net cash position: -$1.03 million (0% of Market Cap)
Founded in 2014 to improve healthcare for America's seniors through technology, Clover Health (NASDAQ: CLOV) provides Medicare Advantage plans for seniors with a focus on affordable care and uses its proprietary Clover Assistant software to help physicians manage patient care.
What Makes CLOV Stand Out?
- Average customer growth of 43.3% over the past two years demonstrates success in acquiring new clients that could increase their spending in the future
- Earnings growth has trumped its peers over the last five years as its EPS has compounded at 15.2% annually
- Free cash flow profile has moved into positive territory over the last five years, indicating the company has passed a significant test
At $4.45 per share, Clover Health trades at 31.3x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Cactus (WHD)
Net cash position: $300.1 million (7.8% of Market Cap)
Named for the spiky wellhead equipment that reminded founders of desert cacti, Cactus (NYSE: WHD) manufactures wellheads, valves, and spoolable pipes used in drilling and producing oil and gas wells.
Why Are We Fans of WHD?
- Annual revenue growth of 28.2% over the last ten years was superb and indicates its market share increased during this cycle
- Strong free cash flow margin of 20.3% enables it to reinvest or return capital consistently
Cactus is trading at $55.03 per share, or 17.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-quality stocks for all market conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
